Lipid Peroxidation Scavengers Prevent the Carbonylation of Cytoskeletal Brain Proteins Induced by Glutathione Depletion

被引:0
作者
Oscar A. Bizzozero
Savanna Reyes
Jennifer Ziegler
Suzanne Smerjac
机构
[1] University of New Mexico—Health Sciences Center,Department of Cell Biology and Physiology
[2] Basic Medical Sciences Building,undefined
来源
Neurochemical Research | 2007年 / 32卷
关键词
Glutathione depletion; Oxidative damage; Protein carbonylation; Reactive oxygen species; Lipid peroxidation;
D O I
暂无
中图分类号
学科分类号
摘要
In this study, we investigated the possible link between lipid peroxidation (LPO) and the formation of protein carbonyls (PCOs) during depletion of brain glutathione (GSH). To this end, rat brain slices were incubated with the GSH depletor diethyl maleate (DEM) in the absence or presence of classical LPO scavengers: trolox, caffeic acid phenethyl ester (CAPE), and butylated hydroxytoluene (BHT). All three scavengers reduced DEM-induced lipid oxidation and protein carbonylation, suggesting that intermediates/products of the LPO pathway such as lipid hydroperoxides, 4-hydroxynonenal and/or malondialdehyde are involved in the process. Additional in vitro experiments revealed that, among these products, lipid hydroperoxides are most likely responsible for protein oxidation. Interestingly, BHT prevented the carbonylation of cytoskeletal proteins but not that of soluble proteins, suggesting the existence of different mechanisms of PCO formation during GSH depletion. In pull-down experiments, β-actin and α/β-tubulin were identified as major carbonylation targets during GSH depletion, although other cytoskeletal proteins such as neurofilament proteins and glial fibrillary acidic protein were also carbonylated. These findings may be important in the context of neurological disorders that exhibit decreased GSH levels and increased protein carbonylation such as Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis.
引用
收藏
页码:2114 / 2122
页数:8
相关论文
共 220 条
[1]  
Stadtman ER(1997)Reactive oxygen-mediated protein oxidation in aging and disease Chem Res Toxicol 10 485-494
[2]  
Berlett BS(2002)Carbonyl modified proteins in cellular regulation, aging, and disease Free Radic Biol Med 32 790-796
[3]  
Levine RL(2001)Protein oxidation in the brain in Alzheimer’s disease Neuroscience 103 373-383
[4]  
Aksenov MY(1998)Increased protein oxidation in human sustantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay J Neurochem 70 268-275
[5]  
Aksenova MV(1997)Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis J Neurochem 69 2064-2074
[6]  
Butterfield DA(2005)Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis J Neurosci Res 81 687-695
[7]  
Geddes JW(2001)Reactive carbonyl formation by oxidative and non-oxidative pathways Front Biosci 6 17-24
[8]  
Markesbery WR(1997)Structural characterization of the products of hydroxyl-radical damage to leucine and their detection on proteins Biochem J 324 41-48
[9]  
Floor E(2005)Metal ions and oxidative protein modification in neurological disease Ann Ist Super Sanita 41 143-164
[10]  
Wetzel MG(1996)The advanced glycation end product, J Biol Chem 271 9982-9986